Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation

American Journal of Cardiology

Volumn 83, Issue 12 A, 1999, Pages 13-18

  Gruver, E James ^a   Fatkin, Diane ^b   Dodds, G Alfred ^c   Kisslo, Joseph ^c   Maron, Barry J ^d   Seidman, J G ^b,e   Seidman, Christine E ^f  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c DUKE UNIVERSITY   (United States)

^d MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN;

CONFERENCE PAPER; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; GENEALOGY; GENETIC PREDISPOSITION; GENETIC RISK; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033577957     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00251-9     Document Type: Conference Paper

References (24)

1. McKenna W.J. Hypertrophic cardiomyopathy. Julian D.G., Camm A.J., Fox K.M., Hall R.J.C., Poole-Wilson P.A. Diseases of the Heart. 1989;9233-9250 Baillière Tindall, London.
2. Jarcho J.A., McKenna W., Pare J.A.P., Solomon S.D., Holcombe R.F., Dickie S., Levi T., Donis-Keller H., Seidman J.G., Seidman C.E. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med. 321:1989;1372-1378.
3. Tanigawa G., Jarcho J.A., Kass S., Solomon S.D., Vosberg H.P., Seidman J.G., Seidman C.E. A molecular basis for familial hypertrophic cardiomyopathy an α/β cardiac myosin heavy chain hybrid gene . Cell. 62:1990;991-998.
4. Geisterfer-Lowrance A.A.T., Kass S., Tanigawa G., Vosberg H.P., McKenna W., Seidman C.E., Seidman J.G. A molecular basis for familial hypertrophic cardiomyopathy a β-cardiac myosin heavy chain gene missense mutation . Cell. 62:1990;999-1006.
5. Watkins H., MacRae C., Thierfelder L., Chou Y.H., Frenneaux M., McKenna W., Seidman J.G., Seidman C.E. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet. 3:1993;333-337.
6. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., Seidman J.G., Seidman C.E. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy a disease of the sarcomere . Cell. 77:1994;701-712.
7. Thierfelder L., MacRae C., Watkins H., Tomfohrde J., Williams M., McKenna W., Bohm K., Noeske G., Schlepper M., Bowcock A., Vosberg H.P., Seidman J.G., Seidman C.E. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA. 90:1993;6270-6274.
8. Watkins H., Conner D., Thierfelder L., Jarcho J.A., MacRae C., McKenna W.J., Maron B.J., Seidman J.G., Seidman C.E. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 11:1995;434-437.
9. Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., Gautel M., Labeit S., James M., Beckmann J., Weissenbach J., Vosberg H.P., Fiszman M., Komajda M., Schwartz K. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 11:1995;438-440.
10. Kimura A., Harada H., Park J.E., Nishi H., Satoh M., Takahashi M., Hiroi S., Sasaoka T., Ohbuchi N., Nakamura T., et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 16:1997;379-382.
11. Poetter K., Jiang H., Hassanzadeh S., Master S.R., Chang A., Dalakas M.C., Rayment I., Sellers J.R., Fananapazir L., Epstein N.D. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 13:1995;63-69.
12. Ciro E., Nichols P.F., Maron B.J. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy two-dimensional echocardiographic analysis . Circulation. 67:1983;6227-6233.
13. Schiller N.B., Shah P.M., Crawford M., Maria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., Silverman N.H., Tajik A.J. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
14. Solomon S.D., Wolff S., Watkins H., Ridker P.M., Come P., MacKenna W.J., Seidman C.E., Lee R. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol. 22:1993;498-505.
15. Klues H.G., Schiffers A., Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients . J Am Coll Cardiol. 26:1995;7699-7708.
16. Jaenicke T., Diederich K.W., Haas W., Schleich J., Lichter P., Pfordt M., Bach A., Vosberg H.P. The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics. 8:1990;194-206.
17. Gibbs R.A., Nguyen P.N., McBride L.J., Koepf S.M., Caskey C.T. Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct sequencing of in vitro amplified cDNA. Proc Natl Acad Sci USA. 86:1989;1919-1923.
18. Cecchi F., Montereggi A., Olivotto I., Marconi P., Dolara A., Maron B.J. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration. Heart. 78:1997;44-49.
19. Watkins H., Rosenzweig A., Hwang D.S., Levi T., McKenna W., Seidman C.E., Seidman J.G. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 326:1992;1108-1114.
20. Rayment I., Holden H.M., Sellers J.R., Fananapazir L., Epstein N.D. Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 92:1995;3864-3868.
21. Holmes K.C., Holmes K.C. The Limits of Reductionism in Biology. 213:1998;76-92 John Wiley & Sons, Chichester (Novartis Foundation Symposium), England.
22. Furberg C.D., Psaty B.M., Manolio T.A., Gardin J.M., Smith V.E., Rautaharju P.M. Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study). Am J Cardiol. 74:1994;236-241.
23. Spirito P., Lakatos E., Maron B.J. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol. 69:1992;1217-1222.
24. Semsarian C., French J., Trent R.J., Richmond D.R., Jeremy R.W. The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy. Aust N Z J Med. 27:1997;51-58.